Please login to the form below

Not currently logged in
Email:
Password:

Patheon

This page shows the latest Patheon news and features for those working in and with pharma, biotech and healthcare.

DSM merges pharma unit with Patheon

DSM merges pharma unit with Patheon

DSM merges pharma unit with Patheon. New company will provide portfolio of development and manufacturing services. ... The merged company will have 2014 sales of around $2bn, a headcount of around 8, 300, and will be led by Patheon's current chief

Latest news

  • Both feet first

    organisations including Catalent Pharma Solutions, Lonza and Patheon offer comprehensive services that have enabled these organisations to become highly integrated with the life sciences companies they support.

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Pharma deals during September 2014 Pharma deals during September 2014

    The contract manufacturing sector is in a state of flux with the acquisition of Patheon last year by DSM and Akorn's acquisition of the ophthalmic manufacturer Excelvision in July this

  • Deal Watch table for November 2013 Deal Watch table for November 2013

    1, 017. Patheon / Royal DSM and JLL Partners. Merger and acquisition. ... DSM and JLL Partners (private equity) acquire. Patheon and merge it with DSM's CMO Pharmaceutical Products Division in a jointly owned Newco.

  • Pharma deals during November 2012 Pharma deals during November 2012

    375. Banner Pharmcaps / Patheon. Acquisition. Gelatin-based oral drug delivery technology.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics